Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

APPOINTMENTS AND ADVANCEMENTS

Oct. 14, 1991

CAL BIO TO ACQUIRE 20% OF SUBSIDIARY

Oct. 14, 1991

DEPRENYL SPINOFF FILES FOR IPO

Oct. 14, 1991

RAT MODEL FOR TYPE 2 DIABETES

Oct. 11, 1991

IMMUNOLOGY, BAXTER FINALIZE MAJOR DEAL

Oct. 11, 1991

XOMA/CENTOCOR TRIAL WINDING DOWN

Oct. 11, 1991

DOW EXTENDS AGREEMENT WITH GENSIA

Oct. 11, 1991

ALKERMES FILES FOR SECONDARY OFFERING

Oct. 11, 1991

ANERGEN RAISES $14 MILLION IN IPO

Oct. 11, 1991

CONGRESSMAN BLASTS AMGEN PROFITS

Oct. 11, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...